| Bioactivity | Risvodetinib is a potent protein tyrosine kinase inhibitor. Risvodetinib involves in synthesis of Abelson protein kinases (c-Abl1, c-Abl2, and c-kit) inhibitor[1][2]. |
| Name | Risvodetinib |
| CAS | 2031185-00-7 |
| Formula | C33H34N8O2 |
| Molar Mass | 574.68 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Werner MH, et al. Preparation of N-[3-[[4-(2-pyridyl)pyrimidin-2-yl]amino]phenyl]-4-[(piperazin-1-yl)methyl]benzamide derivatives as inhibitors of kinases: World Intellectual Property Organization, WO2016172528. 2016-10-27. [2]. WHO Drug Information-World Health Organization (WHO). |
Risvodetinib
CAS: 2031185-00-7 F: C33H34N8O2 W: 574.68
Risvodetinib is a potent protein tyrosine kinase inhibitor. Risvodetinib involves in synthesis of Abelson protein kinase
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.